BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

396 related articles for article (PubMed ID: 23874982)

  • 1. 4-1BB signaling activates the t cell factor 1 effector/β-catenin pathway with delayed kinetics via ERK signaling and delayed PI3K/AKT activation to promote the proliferation of CD8+ T Cells.
    Lee DY; Choi BK; Lee DG; Kim YH; Kim CH; Lee SJ; Kwon BS
    PLoS One; 2013; 8(7):e69677. PubMed ID: 23874982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perturbed differentiation of murine embryonic stem cells upon Pelota deletion due to dysregulated FOXO1/β-catenin signaling.
    Elkenani M; Nyamsuren G; Toischer K; Adham IM; Mohamed BA
    FEBS J; 2021 May; 288(10):3317-3329. PubMed ID: 33245852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 4-1BB Signaling Enhances Primary and Secondary Population Expansion of CD8+ T Cells by Maximizing Autocrine IL-2/IL-2 Receptor Signaling.
    Oh HS; Choi BK; Kim YH; Lee DG; Hwang S; Lee MJ; Park SH; Bae YS; Kwon BS
    PLoS One; 2015; 10(5):e0126765. PubMed ID: 25962156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.
    Sabbagh L; Pulle G; Liu Y; Tsitsikov EN; Watts TH
    J Immunol; 2008 Jun; 180(12):8093-101. PubMed ID: 18523273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reg4-induced mitogenesis involves Akt-GSK3β-β-Catenin-TCF-4 signaling in human colorectal cancer.
    Bishnupuri KS; Sainathan SK; Bishnupuri K; Leahy DR; Luo Q; Anant S; Houchen CW; Dieckgraefe BK
    Mol Carcinog; 2014 Feb; 53 Suppl 1(0 1):E169-80. PubMed ID: 24151146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-1BB signaling activates glucose and fatty acid metabolism to enhance CD8
    Choi BK; Lee DY; Lee DG; Kim YH; Kim SH; Oh HS; Han C; Kwon BS
    Cell Mol Immunol; 2017 Sep; 14(9):748-757. PubMed ID: 26972770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lucidone Promotes the Cutaneous Wound Healing Process via Activation of the PI
    Yang HL; Tsai YC; Korivi M; Chang CT; Hseu YC
    Biochim Biophys Acta Mol Cell Res; 2017 Jan; 1864(1):151-168. PubMed ID: 27816443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells.
    Vangamudi B; Zhu S; Soutto M; Belkhiri A; El-Rifai W
    Mol Cancer; 2011 Mar; 10():32. PubMed ID: 21447180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The B cell antigen receptor regulates the transcriptional activator beta-catenin via protein kinase C-mediated inhibition of glycogen synthase kinase-3.
    Christian SL; Sims PV; Gold MR
    J Immunol; 2002 Jul; 169(2):758-69. PubMed ID: 12097378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 augmented motility of airway epithelial cell BEAS-2B via Akt/GSK-3β signaling pathway.
    Wang WC; Kuo CY; Tzang BS; Chen HM; Kao SH
    J Cell Biochem; 2012 Nov; 113(11):3567-75. PubMed ID: 22740511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-stimulation through 4-1BB/CD137 improves the expansion and function of CD8(+) melanoma tumor-infiltrating lymphocytes for adoptive T-cell therapy.
    Chacon JA; Wu RC; Sukhumalchandra P; Molldrem JJ; Sarnaik A; Pilon-Thomas S; Weber J; Hwu P; Radvanyi L
    PLoS One; 2013; 8(4):e60031. PubMed ID: 23560068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR48, a poor prognostic factor, promotes tumor metastasis and activates β-catenin/TCF signaling in colorectal cancer.
    Wu J; Xie N; Xie K; Zeng J; Cheng L; Lei Y; Liu Y; Song L; Dong D; Chen Y; Zeng R; Nice EC; Huang C; Wei Y
    Carcinogenesis; 2013 Dec; 34(12):2861-9. PubMed ID: 23803691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy.
    Cannons JL; Lau P; Ghumman B; DeBenedette MA; Yagita H; Okumura K; Watts TH
    J Immunol; 2001 Aug; 167(3):1313-24. PubMed ID: 11466348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin and IGF-1 stimulate the beta-catenin pathway through two signalling cascades involving GSK-3beta inhibition and Ras activation.
    Desbois-Mouthon C; Cadoret A; Blivet-Van Eggelpoël MJ; Bertrand F; Cherqui G; Perret C; Capeau J
    Oncogene; 2001 Jan; 20(2):252-9. PubMed ID: 11313952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTEN-mediated Akt/β-catenin/Foxo1 signaling regulates innate immune responses in mouse liver ischemia/reperfusion injury.
    Kamo N; Ke B; Busuttil RW; Kupiec-Weglinski JW
    Hepatology; 2013 Jan; 57(1):289-98. PubMed ID: 22807038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3beta in endothelial cells.
    Joshi MB; Ivanov D; Philippova M; Erne P; Resink TJ
    FASEB J; 2007 Oct; 21(12):3083-95. PubMed ID: 17485554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. POTEE stimulates the proliferation of pancreatic cancer by activating the PI3K/Akt/GSK-3β/β-catenin signaling.
    Hao Q; Gao L; Niu W; Chen L; Zhang P; Chen Z
    Biofactors; 2020 Jul; 46(4):685-692. PubMed ID: 32589786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of glycogen synthase kinase-3beta signaling in hepatocellular carcinoma cells.
    Desbois-Mouthon C; Blivet-Van Eggelpoël MJ; Beurel E; Boissan M; Delélo R; Cadoret A; Capeau J
    Hepatology; 2002 Dec; 36(6):1528-36. PubMed ID: 12447879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chimeric antigen receptors combining 4-1BB and CD28 signaling domains augment PI3kinase/AKT/Bcl-XL activation and CD8+ T cell-mediated tumor eradication.
    Zhong XS; Matsushita M; Plotkin J; Riviere I; Sadelain M
    Mol Ther; 2010 Feb; 18(2):413-20. PubMed ID: 19773745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.